You can read the full article at This study aimed to compare the efficacy of tirzepatide at different doses (5/10/15 mg) with semaglutide (2 mg) in treating type 2 diabetes
According to Kleinman et al., while TB-500 is likely to have additional uses in the skin and in injured organs for tissue repair and regeneration there is no research showing what dosage it may be administered to this end
[14] Patients should be counselled on recognising hypoglycaemia symptomssuch as sweating, tremor, confusion, and palpitationsand advised to carry glucose tablets or a sugary drink
That page belongs to the lab, not to us
However, when thyroid disease enters the picture, particularly autoimmune conditions like Hashimotos thyroiditis or concerns about thyroid nodules and cancer risk, the conversation around GLP-1s becomes more complex
For example, 40 units from a 2.5 mg/mL vial: (40 100) 2.5 = 1.0 mg